Total | Male | Female | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Underlying cause of death (ICD-9 codes; ICD-10 codes) | Observed | Expected | Person-years | SMR (95% CI) | EAR (95% CI) | Observed | Expected | Person-years | SMR (95% CI) | EAR (95% CI) | Observed | Expected | Person-years | SMR (95% CI) | EAR (95% CI) |
All causes (001-E999; A00-R99,V01-Y89) | 1461 | 1114.69 | 50 147 | 1.31 (1.24 to 1.38) | 69 (62 to 76) | 1037 | 797.07 | 33 858 | 1.30 (1.22 to 1.38) | 71 (62 to 80) | 424 | 317.62 | 16 288 | 1.34 (1.21 to 1.47) | 65 (53 to 78) |
All causes (001-E999; A00-R99,V01-Y89) excluding oesophageal malignancy (150.0–150.9; C15) | 1376 | 1106.36 | 50 147 | 1.24 (1.18 to 1.31) | 54 (47 to 60) | 969 | 789.59 | 33 858 | 1.23 (1.15 to 1.31) | 53 (45 to 61) | 407 | 316.77 | 16 288 | 1.29 (1.16 to 1.42) | 55 (44 to 67) |
Neoplastic mortality (140–239, 273–273.3, 273.9; C00–D48) | 384 | 307.73 | 50 147 | 1.25 (1.13 to 1.38) | 15 (12 to 19) | 291 | 224.29 | 33 858 | 1.30 (1.15 to 1.46) | 20 (15 to 24) | 93 | 83.44 | 16 288 | 1.12 (0.90 to 1.37) | 6 (2 to 10) |
All neoplasms (140–149, 151–239, 273–273.3, 273.9; C00–C14, C16–D48) excluding oesophageal cancer (150.0–150.9; C15) | 299 | 299.40 | 50 147 | 1.00 (0.89 to 1.12) | 0 (0 to 0) | 223 | 216.81 | 33 858 | 1.03 (0.90 to 1.17) | 2 (0 to 3) | 76 | 82.59 | 16 288 | 0.92 (0.73 to 1.15) | −4 (−7 to 1) |
Malignant neoplasms of the oesophagus (150.0–150.9; C15) | 85 | 8.33 | 50 147 | 10.20 (8.15 to 12.61) | 15 (12 to 19) | 68 | 7.48 | 33 858 | 9.09 (7.06 to 11.53) | 18 (13 to 22) | 17 | 0.85 | 16 288 | 19.90 (11.59 to 31.86) | 10 (5 to 15) |
Malignant neoplasms of the stomach (151.0–151.9; C16) | 8 | 7.43 | 50 147 | 1.08 (0.47 to 2.12) | 0 (0 to 0) | 5 | 5.94 | 33 858 | 0.84 (0.27 to 1.96) | 0 (−1 to 0) | 3 | 1.49 | 16 288 | 2.02 (0.42 to 5.89) | 1 (−1 to 2) |
Malignant neoplasms of the oesophagus (150.0–150.9; C15) or stomach (151.0–151.9; C16, C26.9) | 95 | 15.76 | 50 147 | 6.03 (4.88 to 7.37) | 16 (12 to 19) | 75 | 13.42 | 33 858 | 5.59 (4.40 to 7.01) | 18 (14 to 23) | 20 | 2.34 | 16 288 | 8.54 (5.22 to 13.19) | 11 (6 to 16) |
Malignant neoplasms of the trachea, bronchus and lung (162.0–162.9; C33–C34) | 65 | 74.24 | 50 147 | 0.88 (0.68 to 1.12) | −2 (−3 to −1) | 51 | 54.09 | 33 858 | 0.94 (0.70 to 1.24) | −1 (−2 to 0) | 14 | 20.15 | 16 288 | 0.70 (0.38 to 1.17) | −4 (−7 to 1) |
Malignant neoplasms of the colon, rectosigmoid junction and anus (153.0–154.9; C18–C21) | 31 | 27.75 | 50 147 | 1.12 (0.76 to 1.59) | 1 (0 to 1) | 19 | 19.85 | 33 858 | 0.96 (0.58 to 1.49) | 0 (−1 to 0) | 12 | 7.90 | 16 288 | 1.52 (0.79 to 2.65) | 3 (0 to 5) |
Non-neoplastic mortality | 33 858 | 16 288 | |||||||||||||
Diseases of the circulatory system (390.0–459.9, 93, 94.8, 98.8, 115, 289, 435, 999.1; I00–I99, G45, M30, M31, N28, R58) | 443 | 358.83 | 50 147 | 1.24 (1.12 to 1.36) | 17 (13 to 20) | 332 | 262.48 | 33 858 | 1.27 (1.13 to 1.41) | 21 (16 to 25) | 111 | 96.35 | 16 288 | 1.15 (0.95 to 1.39) | 9 (4 to 14) |
Acute myocardial infarction (410.00–410.92; I21–I22) | 70 | 63.52 | 50 147 | 1.10 (0.86 to 1.39) | 1 (0 to 2) | 52 | 49.08 | 33 858 | 1.06 (0.79 to 1.39) | 1 (0 to 2) | 18 | 14.44 | 16 288 | 1.25 (0.74 to 1.97) | 2 (0 to 4) |
Ischaemic heart disease (411.0–414.9, 429.2; I23–25, I20) | 155 | 111.51 | 50 147 | 1.39 (1.18 to 1.63) | 9 (6 to 11) | 120 | 87.46 | 33 858 | 1.37 (1.14 to 1.64) | 10 (6 to 13) | 35 | 24.05 | 16 288 | 1.46 (1.01 to 2.02) | 7 (3 to 11) |
Cerebrovascular disease (430.0–438.9, 94.87; I60–69, G45) | 71 | 66.50 | 50 147 | 1.07 (0.83 to 1.35) | 1 (0 to 2) | 58 | 44.25 | 33 858 | 1.31 (1.00 to 1.69) | 4 (2 to 6) | 13 | 22.25 | 16 288 | 0.58 (0.31 to 1.00) | −6 (−9 to −2) |
Diseases of the respiratory system (460.00–519.99, 3.22, 12.3, 95.1, 334, 997.3; J00–J99, R09) | 177 | 117.33 | 50 147 | 1.51 (1.29 to 1.75) | 12 (9 to 15) | 114 | 83.23 | 33 858 | 1.37 (1.13 to 1.65) | 9 (6 to 12) | 63 | 34.10 | 16 288 | 1.85 (1.42 to 2.36) | 18 (11 to 24) |
Diseases of the digestive system (520.00–579.99, 17.8, 32.83, 95.2, 98.86, 99.56, 14.8; K00–K93, R11, R18) | 79 | 35.74 | 50 147 | 2.20 (1.75 to 2.75) | 9 (6 to 11) | 49 | 25.04 | 33 858 | 1.96 (1.45 to 2.59) | 7 (4 to 10) | 30 | 10.70 | 16 288 | 2.80 (1.89 to 4.00) | 12 (7 to 17) |
*Barrett’s oesophagus defined as ICD-9 code 530.85, or 530.2 with SNOMED M73330.
EAR, excess absolute risk; ICD-O, International Classification of Diseases for Oncology; SMR, standardised mortality ratio; SNOMED, Systematised Nomenclature of Medicine.